Full text is available at the source.
Abstract
Addition of glucagon-like peptide-1 receptor agonists (GLP-1RAs) to basal insulin may decrease insulin requirements.
- The effect of GLP-1RAs on insulin use has been observed in some cases.
- It remains uncertain if GLP-1RAs can lead to complete discontinuation of insulin.
- Further investigation is needed to clarify the potential for insulin reduction or elimination.
Simplified